Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The gene expression market was valued at USD 14.68 Billion in 2025. It is poised to grow at a CAGR of 10.40% during the forecast period of 2026-2035, and reach USD 39.48 Billion by 2035. Rising demand for precision medicine and increased adoption of advanced gene expression technologies are driving market growth, supported by expanding research activities, clinical applications, and continuous innovations in genomic analysis tools.
Base Year
Historical Period
Forecast Period
In January 2026, Illumina unveiled the Billion Cell Atlas, a large-scale dataset mapping gene expression across one billion cells, enabling AI-driven drug discovery and advancing disease biology and precision medicine research.
In October 2025, Plasmidsaurus launched an ultrafast RNA sequencing service delivering analyzed gene expression data within days, significantly improving affordability, turnaround time, and accessibility for researchers globally.
In June 2025, Google DeepMind introduced AlphaGenome, an advanced AI model designed to predict how DNA sequences influence gene regulation, enhancing genomic research capabilities and accelerating gene expression discoveries.
Compound Annual Growth Rate
10.4%
Value in USD Billion
2026-2035
*this image is indicative*
The market is expanding rapidly due to advancements in molecular biology and precision medicine. Technologies such as RNA sequencing are enabling deeper insights into cellular functions, driving demand across research and clinical applications. Increasing focus on personalized therapies, biomarker discovery, and disease diagnostics continues to fuel innovation, while investments in biotechnology and genomics research further support sustained market growth globally. The market reached a value of approximately USD 14.68 Billion in 2025.
Advancements in RNA Sequencing Accelerating the Market Demand
Increasing demand for precision medicine and rising investments in genomics research are key drivers propelling the gene expression market. For instance, in October 2025, Plasmidsaurus introduced an ultrafast RNA sequencing service that significantly reduces turnaround time while improving affordability and accessibility for researchers. This development enhances workflows involving transcriptomics, qPCR validation, and differential expression studies. During the forecast period, such innovations are expected to accelerate adoption, streamline research processes, and expand market penetration across clinical and academic applications.
Key trends shaping the market include rising adoption of single-cell RNA-seq, AI-driven analysis, and precision medicine advancements.
Increasing AI-Driven Genomics Innovations to Boost the Market Value
Rising adoption of artificial intelligence in genomics and increasing investments in large-scale biological datasets are key factors influencing market trends. In January 2026, Illumina introduced the Billion Cell Atlas, a comprehensive dataset mapping gene activity across vast cell populations, strengthening applications in epigenomics alongside RNA sequencing and microarray technologies. In the forecast period, such initiatives will drive data-driven innovation, improving scalability and accelerating precision medicine advancements.
Market Breakup by Products and Services
Market Breakup by Technology
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Consumables Expected to Lead the Market Share by Product and Services
Consumables accounted for over 48% of the gene expression market share in the historical period, driven by their recurring usage in laboratory workflows and high demand across research and clinical settings. Products supporting transcriptomics studies, including reagents and kits, contribute significantly to this dominance, as they are essential for accurate and scalable gene expression profiling across diverse applications.
North America is expected to dominate the market with a share exceeding 42% in the historical period, supported by strong research infrastructure and funding. The region’s leadership is reinforced by widespread adoption of advanced technologies such as RNA sequencing, enabling precise gene expression analysis and accelerating innovation in diagnostics, drug discovery, and personalized medicine across pharmaceutical and biotechnology sectors.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Illumina Inc., headquartered in San Diego, California, and founded in 1998, is a global leader in genomic technologies. Its portfolio includes sequencing platforms, reagents, and gene expression solutions widely used in research and clinical settings, particularly enabling advanced transcriptomics applications.
Thermo Fisher Scientific, headquartered in Waltham, Massachusetts, and established in 2006, provides comprehensive life sciences solutions. Its gene expression portfolio includes PCR systems, reagents, and sequencing technologies supporting advanced qPCR workflows. The company continues expanding molecular diagnostics capabilities through strategic product innovations and partnerships to strengthen precision medicine and research applications globally.
Promega Corporation, founded in 1978 and headquartered in Madison, Wisconsin, develops reagents, assays, and instrumentation for life sciences research. Its gene expression portfolio includes luciferase assays, RNA analysis tools, and systems supporting gene regulation studies. The company focuses on enabling cellular and molecular research through innovative solutions tailored to academic, clinical, and pharmaceutical applications.
Revvity Inc., formerly PerkinElmer, Inc., headquartered in Waltham, Massachusetts, and established in 1937, provides diagnostic and life sciences solutions. Its gene expression offerings include reagents, detection systems, and imaging platforms supporting epigenomics and biomarker discovery. The company emphasizes precision health by advancing technologies for disease detection, translational research, and drug development across global markets.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market are Agilent Technologies Inc., Oxford Nanopore Technologies Inc., F. Hoffmann La Roche Ltd., PacBio, Bio-Rad Laboratories Inc., Danaher Life Sciences, Takara Bio Inc., and QIAGEN.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Products and Services |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share